跳至主要内容
临床试验/NCT03364920
NCT03364920Unknown不适用

Serum Maresin-1 Level Predicts the Disease Severity and Clinical Outcomes of Severe Acute Pancreatitis Patients

Weiqin Li0 个研究点目标入组 200 人开始时间: 2018年1月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
200
主要终点
mortality

研究概览

简要总结

This is a retrospective study about serum Maresin-1 level in different severe acute pancreatitis patients. The investigators want to study the correlation between the level of serum Maresin-1 and the severity of SAP, of course the clinical outcomes. The investigators want to find some biomarkers and strategy target drugs of severe acute pancreatitis.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Clinical diagnosis of Severe Acute Pancreatitis
  • Biliary pancreatitis
  • 7 days of the onset

排除标准

  • Surgical patients
  • Serious diseases and infection
  • Alcoholic pancreatitis
  • Hypertriglyceridemia pancreatitis
  • Disorder of Glucolipide Metabolism:diabetes mellitus, hypertriglyceridemia, BMI>30

结局指标

主要结局

mortality

时间窗: up to 28 days

The level of serum maresin-1 predicts the severity of severe acute pancreatitis

次要结局

  • The incidence of MODS(through study completion, an average of 1 year)
  • The incidence of IPN(through study completion, an average of 1 year)

研究者

发起方
Weiqin Li
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Weiqin Li

Doctor

Nanjing University School of Medicine

相似试验